To view videos with matches, highlights & goals, previews, iconic moments and more, visit OneFootball.

Wegovy (semaglutide) will no longer be available through Hims & Hers Health, as Novo Nordisk has ended its short-lived partnership.

Our writer reveals what he thinks is the most exciting from the four investments he made in his Stocks and Shares ISA last ...

Enquanto o presidente americano Donald Trump e seus assessores começam a avaliar substitutos para o presidente do Federal ...

There is always a challenging moment in every investor’s favorite stock and portfolio, especially when said businesses are ...

Backed by tech billionaires, the crypto-focused digital startup bank's timely application reflects the current administration ...

The application follows on the heels of Circle and Wise, as crypto and payment companies seek crypto custody approval and ...

CVS says the decision to cover Wegovy and exclude Zepbound is "forcing the drug manufacturers to compete with one another" and will encourage both Eli Lilly and Novo Nordisk to lower prices for their ...

Spain is investigating Novo Nordisk over concerns it may be illegally advertising its weight loss drugs Ozempic and Wegovy ...

Earlier this week, the pharma giant publicly accused Hims & Hers of “deceptive” marketing that is putting patient safety at risk.

The Howard County Board of Education is suing Eli Lilly and Co., Novo Nordisk, CVS, UnitedHealth Group and several other drug ...

IcoSema, a combination therapy of basal insulin icodec and semaglutide, achieves a noninferior reduction in A1c levels compared with basal-bolus therapy in adults with T2D.